Treatment Resistant Epilepsy and N-Acetyl Cysteine
Status:
Withdrawn
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a study to find out whether the dietary amino acid supplement, N-acetyl cysteine
(NAC) is helpful in reducing the frequency of seizures in children with autism and comorbid
epilepsy whose seizures are not responding well to usual medical treatment. The study is also
looking to see if this supplement is helpful for immediate and ongoing treatment of symptoms
of irritability. Additionally, this study will also look to see if certain substances in the
blood that measure a specific type of stress on cells in the body can help tell us how NAC
may be helping.